Novo Nordisk Joins RE100 with 100% Renewable Ambition

Primary tabs

Novo Nordisk Joins RE100 with 100% Renewable Ambition

tweet me:
Novo Nordisk is proud to join #RE100 and further actions to increase renewable power. #COP21

Multimedia from this Release


Global diabetes company, Novo Nordisk, produces nearly half of the world’s insulin at its production sites across the world. A new commitment to renewable electricity ensures meeting the needs for the company’s products is done in a sustainable way. 

Monday, December 7, 2015 - 9:00am

CONTENT: Press Release

PARIS, France, December 7, 2015 /3BL Media/ – Novo Nordisk has joined RE100 with an ambition to use 100% renewable electricity at all its global production sites by 2020. By joining the RE100, Novo Nordisk together with more than 50 global companies, is working to increase corporate demand for renewable energy.

“Switching to renewable electricity is a strategy that aims to reduce long-term costs and contributes to global climate change goals,” says Dorethe Nielsen, senior director for Corporate Environmental Management at Novo Nordisk. “We know that as more companies invest in renewable power, green technology is likely to get more efficient, less costly and become a more attractive power source.”

Novo Nordisk’s renewable energy ambition is global and covers all the company’s production sites. Since 2007, the company’s production sites in Denmark, Brazil, Japan and most recently China have been using electricity from renewable sources. In October, Novo Nordisk’s production site in Tianjin, China signed an agreement on purchasing electricity from a wind farm in Inner Mongolia.

The company’s production sites in the US, France, Russia and Algeria will enter renewable electricity agreements going forward.

For production sites in some countries, the company’s preferred solution of sourcing on-site renewable energy is not feasible due to location and space available. This means that some production sites are dependent on the electrical grid owners to supply the energy.

About RE100

RE100 is a collaborative initiative of influential businesses committed to 100% renewable electricity, working to massively increase corporate demand for renewable energy. Companies joining RE100 are encouraged to set a public goal to procure 100% of their electricity from renewable sources of energy by a specified year.

The private sector accounts for more than half of the world’s electricity consumption. Switching this demand to renewables will accelerate the transformation of the global energy market and aid the transition to a low carbon economy. RE100 is led by The Climate Group in partnership with CDP, as part of the We Mean Business coalition.

For more information, visit

About Novo Nordisk

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. We believe that a healthy economy, environment and society are fundamental to long-term value creation. This is why we manage our business in accordance with the Triple Bottom Line business principle and consider the financial, environmental and social impact of our business decisions.

For more information, visit

Keywords: Energy | COP21 | Novo Nordisk | Paris | RE100 | Renewable Energy | renewable electricity | sustainability

CONTENT: Press Release